About NanoBioDesign
NanoBioDesign is a life science company developing a commercialising a novel approach to CYP P450 testing based upon the patented concept of ‘molecular lego’. NBD’s electrochemical array technology produces high information content data relating to how a chemical entity interacts with a CYP P450 and also allows complex drug-drug interaction to be studied quickly and cost effectively.
NBD was formed in 2001 as a spin out from Imperial College, London and has research and development activities based at Imperial College and also at the University of Turin, Italy.
NBD has an experienced management team and board of directors as well as a dedicated group of investors who are committed to delivering our new paradigm in CYP P450 testing to the marketplace.
